For people with depression that hasn't responded to other treatments, using a nasal spray called esketamine for six months may help them feel less hopeless, based on a survey that measures how hopeless people feel.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses the phrase 'is associated with', which indicates a statistical link rather than a direct cause. It also uses 'suggesting a potential impact', which further softens the language to imply possibility rather than certainty.
Context Details
Domain
medicine
Population
human
Subject
Adults with treatment-resistant depression
Action
is associated with a reduction in
Target
hopelessness levels as measured by the Beck Hopelessness Scale (mean decrease of 4.3 points from baseline)
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
This study gave people with severe depression a nasal spray called esketamine for six months and found they felt less hopeless over time — which is exactly what the claim says.